The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring.
Stefano Omboni, Elisa Sala
https://pubmed.ncbi.nlm.nih.gov/25578090/Actively Recruiting
Led by Italian Institute of Telemedicine · Updated on 2026-11-04
40000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating blood pressure control in patients with hypertension through a large observational study conducted across multiple community pharmacies in Italy. This study aims to analyze 24-hour ambulatory blood pressure monitoring ABPM data collected in pharmacies to understand blood pressure management in a community setting and to assess the usefulness of telehealth networks involving pharmacists for hypertension screening and control. Participants undergo 24-hour or home blood pressure monitoring performed in participating pharmacies under medical supervision and prescription by their general practitioners. The service uses telemonitoring and telereporting systems to collect data centrally. The study includes patients both treated and untreated with antihypertensive drugs, reflecting real-world blood pressure control and screening scenarios according to current guidelines and local regulations. During the study, participants blood pressure recordings and clinical data are analyzed to measure blood pressure control rates over a 10-year period, including 24-hour, office, daytime, and nighttime blood pressure control. The study also evaluates the prevalence of white-coat and masked hypertension and blood pressure control in risk subgroups. The project runs from October 2010 through December 2030, involving ongoing data collection from community pharmacies equipped for this service.
CONDITIONS
Telemonitoring of Blood Pressure in Local Pharmacies
S
Stefano Omboni, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Italian Institute of Telemedicine
Lead Sponsor
Italian Society of Hypertension
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) at the pharmacy for blood pressure monitoring setup
Duration - Single monitoring period as prescribed by the doctor
Participants undergo 24-hour or home blood pressure monitoring through community pharmacies using telemonitoring systems under medical supervision.
1 monitoring period with data collection
Duration - Up to 10 years
Researchers analyze collected blood pressure data and clinical information to assess blood pressure control rates and patterns over time.
Periodic data collection from pharmacies
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Stefano Omboni, Elisa Sala
https://pubmed.ncbi.nlm.nih.gov/25578090/Stefano Omboni, Mauro Tenti
https://pubmed.ncbi.nlm.nih.gov/30037524/Stefano Omboni, Luca Campolo, Edoardo Panzeri
https://pubmed.ncbi.nlm.nih.gov/32536214/Stefano Omboni, Tommaso Ballatore, Franco Rizzi...
https://pubmed.ncbi.nlm.nih.gov/34587198/Stefano Omboni, Richard J McManus, Hayden B Bosworth...
https://pubmed.ncbi.nlm.nih.gov/32921195/Stefano Omboni
https://pubmed.ncbi.nlm.nih.gov/37017033/Stefano Omboni, Nadia A Khan, Vijay Kunadian...
https://pubmed.ncbi.nlm.nih.gov/37315119/Stefano Omboni, Marina Caserini, Claudio Coronetti
https://pubmed.ncbi.nlm.nih.gov/27072129/Stefano Omboni, Antonio Mancinelli, Franco Rizzi...
https://pubmed.ncbi.nlm.nih.gov/30976783/Stefano Omboni, Tommaso Ballatore, Franco Rizzi...
https://pubmed.ncbi.nlm.nih.gov/34102664/Italian Institute of Telemedicine
Lead Sponsor
Italian Society of Hypertension
Collaborating Sponsor